Published in Ann Intern Med on June 01, 1976
Coronary artery occlusion and alcohol intake. Br Heart J (1977) 0.84
Acute heavy alcohol intake increases silent myocardial ischaemia in patients with stable angina pectoris. Heart (1996) 0.81
Cefotetan-induced disulfiram-type reactions and hypoprothrombinemia. Antimicrob Agents Chemother (1987) 0.75
Acute effect of decaffeinated coffee on heart rate, blood pressure, and exercise performance in healthy subjects. J Natl Med Assoc (1988) 0.75
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol (2001) 5.25
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol (2000) 3.04
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet (1991) 2.26
A dedicated cone-beam CT system for musculoskeletal extremities imaging: design, optimization, and initial performance characterization. Med Phys (2011) 2.20
Effect of passive smoking on angina pectoris. N Engl J Med (1978) 2.17
Rural and urban differences in stage at diagnosis of colorectal and lung cancers. Br J Cancer (2001) 2.12
Carbon monoxide effect on exercise-induced angina pectoris. Ann Intern Med (1973) 2.10
Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer (2000) 1.97
Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer (2004) 1.80
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77
Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc (1998) 1.77
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer (2005) 1.71
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. Br J Cancer (2006) 1.66
EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group. Eur J Cancer (1996) 1.58
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites. Clin Cancer Res (1999) 1.57
Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br J Cancer (2002) 1.55
Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br J Cancer (2011) 1.53
Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. Eur J Cancer (2001) 1.52
Effects of verapamil on myocardial performance in coronary disease. Circulation (1979) 1.50
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. Eur J Cancer (2002) 1.49
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol (2003) 1.48
Carbon monoxide and coronary heart disease: A review. Environ Res (1975) 1.47
New transtracheal bronchoalveolar lavage technique for the diagnosis of respiratory disease in sheep. Vet Rec (2005) 1.41
Systematic review of cancer treatment programmes in remote and rural areas. Br J Cancer (1999) 1.39
Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med (1974) 1.34
Effect of carbon monoxide on exercise performance in chronic obstructive pulmonary disease. Am J Med (1977) 1.32
Mothers' caries increases odds of children's caries. J Dent Res (2010) 1.30
Carboxyhemoglobin caused by smoking nonnicotine cigarettes. Effects in angina pectoris. Circulation (1971) 1.27
Phase I and pharmacokinetic study of rhizoxin. Cancer Res (1992) 1.26
Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol (1987) 1.26
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. Br J Cancer (2009) 1.25
Attitudes and practice in the management of metastatic colorectal cancer in Britain. Colorectal Cancer Working Party of the UK Medical Research Council. Clin Oncol (R Coll Radiol) (1997) 1.24
Comparative genomic hybridization and chromosomal instability in solid tumours. Br J Cancer (1999) 1.24
Phase I and pharmacokinetic study of flavone acetic acid. Cancer Res (1987) 1.24
Increased prevalence of extended spectrum beta lactamase producers in neonatal septicaemic cases at a tertiary referral hospital. Indian J Med Microbiol (2008) 1.23
Clinical characteristics of patients younger than 60 years with mitral anular calcium: comparison with age- and sex-matched control subjects. Am J Cardiol (1984) 1.22
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. Clin Cancer Res (1998) 1.21
Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil. Oncogene (2006) 1.20
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester). Cancer Res (1986) 1.19
Response of patients and physicians to mass screening for coronary risk factors. Circulation (1975) 1.19
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion. Cancer Res (1993) 1.18
Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors. Ann Oncol (2002) 1.16
Effect of freeway travel on angina pectoris. Ann Intern Med (1972) 1.16
Incidence of ruptured chordae tendineae in the mitral valvular prolapse syndrome: an echocardiographic study. Chest (1979) 1.15
cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. Cancer Treat Rep (1980) 1.15
Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation (1974) 1.14
Family members as third parties in dyadic family conflict: strategies, alliances, and outcomes. Child Dev (1988) 1.13
Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer. Int J Oncol (2001) 1.09
Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer (2000) 1.08
Detection of Mycobacterium bovis infection in skin test-negative cattle with an assay for bovine interferon-gamma. Vet Rec (1994) 1.07
Diurnal variation of plasma catecholamines and systolic time intervals. Chest (1973) 1.07
Neonatal extracorporeal membrane oxygenation: practice patterns and predictors of outcome in the UK. Arch Dis Child Fetal Neonatal Ed (2008) 1.07
Comparative genomic hybridization analysis of chromosomal alterations induced by the development of resistance to thymidylate synthase inhibitors. Cancer Res (1998) 1.06
Biocontrol of Bacillus subtilis against Fusarium verticillioides in vitro and at the maize root level. Res Microbiol (2005) 1.06
Aggravation of angina pectoris by two percent carboxyhemoglobin. Am Heart J (1981) 1.06
Five-year follow-up of maximal treadmill stress test in asymptomatic men and women. Circulation (1980) 1.05
Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors. Cancer Res (2001) 1.04
Colorectal cancer genomics: evidence for multiple genotypes which influence survival. Br J Cancer (2001) 1.04
Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc (1999) 1.04
Hypertension therapy in the older adults-do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly. J Hum Hypertens (2012) 1.04
Treadmill stress test in left ventricular hypertrophy. Chest (1973) 1.03
Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure. Am J Cardiol (1977) 1.02
Effect of prazosin vs placebo on chronic left ventricular heart failure. Circulation (1979) 1.02
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer. Br J Cancer (1998) 1.02
Cysticercosis of extraocular muscle. J Pediatr Ophthalmol Strabismus (1994) 1.02
Genetic services for hereditary breast/ovarian and colorectal cancers - physicians' awareness, use and satisfaction. Community Genet (2008) 1.01
Bolus/infusional 5-fluorouracil and folinic acid for metastatic colorectal carcinoma: are suboptimal dosages being used in the UK? Br J Cancer (1994) 1.00
Effect of carbon monoxide exposure on intermittent claudication. Circulation (1974) 1.00
Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate. Circulation (1977) 1.00
Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use. Drugs (1982) 1.00
Hemodynamics and echocardiograms before and after cardioversion of atrial fibrillation to normal sinus rhythm. Chest (1979) 0.99
c-erbB-2 is not a major factor in the development of colorectal cancer. Br J Cancer (2002) 0.99
Pulsating enophthalmos in aplasia of sphenoid wing. Indian J Ophthalmol (1993) 0.99
Use of capecitabine in management of early colon cancer. Cancer Manag Res (2011) 0.99
Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034. Clin Cancer Res (2000) 0.98
Prevalence of coronary risk factors in healthy adult Kuwaitis. Int J Food Sci Nutr (2001) 0.97
Bypass graft surgery versus medical therapy of angina pectoris. Am J Cardiol (1974) 0.97
Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response. Br J Cancer (2009) 0.97
Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study. Support Care Cancer (2006) 0.96
Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group. J Clin Oncol (1996) 0.96
Medical treatment of angina pectoris. 8. Miscellaneous antianginal drugs. Am Heart J (1973) 0.96
Surgical management of coronary arterial disease in the elderly. Coron Artery Dis (1998) 0.96
Gastric tuberculosis. Endoscopy (1982) 0.96
Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer (1998) 0.95
Changes in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther (1982) 0.95
Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes. Clin Pharmacol Ther (2010) 0.95
A phase II study of Tomudex in relapsed epithelial ovarian cancer. Ann Oncol (1995) 0.95
Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris. N Engl J Med (1969) 0.94
Atrioventricular block in familial hemochromatosis treated by permanent synchronous pacemaker. Arch Intern Med (1969) 0.94
Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation (1977) 0.94
Therapeutic opportunities from tumour biology in metastatic colon cancer. Eur J Cancer (2000) 0.93